[The anticoagulant of the lupus type: a thrombotic risk factor]

Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha.

Journal of thrombosis and haemostasis : JTH·2003

Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin.

Thrombosis research·2001

[Behcet's disease manifested as a intracranial aneurysm].

La Revue de medecine interne·2001

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis.

Thrombosis and haemostasis·2000

Erythroblastic synartesis: an auto-immune dyserythropoiesis.

Blood·1999

Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude.

Thrombosis research·1999

Inflammatory pseudotumor of lymph nodes.

Annales de medecine interne·2004

[Necrolytic migratory erythema revealing glucagonoma without diabetes].

Annales de medecine interne·2004

[Bilateral primary non-Hodgkin's lymphomas of the adrenals].

Annales de medecine interne·2004

[Acute "pseudo-angiocholitis" due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis].

Annales de medecine interne·2004

[Slipped capital femoral epiphysis associated with hyperparathyroidism. A case report].

Annales de medecine interne·2004

[Chronic fever revealing an urachal cyst].

Annales de medecine interne·2004

Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan.

Cureus·2026

From inflammation to rupture: advances in the pathogenesis of pseudoaneurysm formation in Vascular Behçet's Disease.

Frontiers in immunology·2026

TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.

Frontiers in immunology·2026

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.

Frontiers in immunology·2026

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities.

MedComm·2026

Molecular basis of post-translational neoantigen generation in rheumatoid arthritis: breaking immunological tolerance and implications for targeted therapy.

Frontiers in immunology·2026

Related Experiment Videos

[The anticoagulant of the lupus type: a thrombotic risk factor]

Related Concept Videos

Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha.

Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin.

[Behcet's disease manifested as a intracranial aneurysm].

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis.

Erythroblastic synartesis: an auto-immune dyserythropoiesis.

Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude.

Inflammatory pseudotumor of lymph nodes.

[Necrolytic migratory erythema revealing glucagonoma without diabetes].

[Bilateral primary non-Hodgkin's lymphomas of the adrenals].

[Acute "pseudo-angiocholitis" due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis].

[Slipped capital femoral epiphysis associated with hyperparathyroidism. A case report].

[Chronic fever revealing an urachal cyst].

Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan.

From inflammation to rupture: advances in the pathogenesis of pseudoaneurysm formation in Vascular Behçet's Disease.

TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities.

Molecular basis of post-translational neoantigen generation in rheumatoid arthritis: breaking immunological tolerance and implications for targeted therapy.

Related Experiment Videos

[The anticoagulant of the lupus type: a thrombotic risk factor]

Related Concept Videos

Related Articles